1. 864 The mesenchymal stromal compartment in colorectal cancer greatly alters the innate tumour immune microenvironment both in 2D and 3D culture systems. (9th November 2020) Authors: Leonard, Niamh; Treacy, Oliver; Egan, Hannah; O'Malley, Grace; Bort, Elena Tomas; Peerani, Eleonora; Ritter, Thomas; Loessner, Daniela; Egan, Laurence; Ryan, Aideen Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 864 The mesenchymal stromal compartment in colorectal cancer greatly alters the innate tumour immune microenvironment both in 2D and 3D culture systems. (9th November 2020) Authors: Leonard, Niamh; Treacy, Oliver; Egan, Hannah; O'Malley, Grace; Bort, Elena Tomas; Peerani, Eleonora; Ritter, Thomas; Loessner, Daniela; Egan, Laurence; Ryan, Aideen Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 865 Sugar high: Does the sialic acid profile of cancer-associated fibroblasts induce a more tumour-permissive microenvironment?. (10th December 2020) Authors: Egan, Hannah; Treacy, Oliver; Lynch, Kevin; Leonard, Niamh; Nader, Amir; Sheehan, Margaret; Hynes, Sean; Egan, Laurence; Ritter, Thomas; Daly, John; Hogan, Aisling; Michael, O; Ryan, Aideen Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 865 Sugar high: Does the sialic acid profile of cancer-associated fibroblasts induce a more tumour-permissive microenvironment?. (9th November 2020) Authors: Egan, Hannah; Treacy, Oliver; Lynch, Kevin; Leonard, Niamh; Nader, Amir; Sheehan, Margaret; Hynes, Sean; Egan, Laurence; Ritter, Thomas; Daly, John; Hogan, Aisling; Michael, O; Ryan, Aideen Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti‐donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?. Issue 1 (4th December 2012) Authors: Griffin, Matthew D; Ryan, Aideen E; Alagesan, Senthilkumar; Lohan, Paul; Treacy, Oliver; Ritter, Thomas Journal: Immunology and cell biology Issue: Volume 91:Issue 1(2013) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis. (1st January 2021) Authors: Naicker, Serika D; Feerick, Claire L; Lynch, Kevin; Swan, Dawn; McEllistrim, Cian; Henderson, Robert; Leonard, Niamh A; Treacy, Oliver; Natoni, Alessandro; Rigalou, Athina; Cabral, Joana; Chiu, Christopher; Sasser, Kate; Ritter, Thomas; O'Dwyer, Michael; Ryan, Aideen E Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat. (16th May 2018) Authors: Lohan, Paul; Treacy, Oliver; Morcos, Maurice; Donohoe, Ellen; O'donoghue, Yvonne; Ryan, Aideen E.; Elliman, Stephen J.; Ritter, Thomas; Griffin, Matthew D. Journal: Stem cells Issue: Volume 36:Number 8(2018) Page Start: 1210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mesenchymal stem cell therapy to promote corneal allograft survival: current status and pathway to clinical translation. Issue 6 (December 2016) Authors: Murphy, Nick; Lynch, Kevin; Lohan, Paul; Treacy, Oliver; Ritter, Thomas Journal: Current opinion in organ transplantation Issue: Volume 21:Issue 6(2016:Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mesenchymal stem cell therapy to promote corneal allograft survival: current status and pathway to clinical translation. Issue 6 (December 2016) Authors: Murphy, Nick; Lynch, Kevin; Lohan, Paul; Treacy, Oliver; Ritter, Thomas Journal: Current opinion in organ transplantation Issue: Volume 21:Issue 6(2016:Dec.) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TNF‐α/IL‐1β—licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell‐mediated induction of Foxp3+ regulatory T cells in the lung. Issue 8 (20th May 2019) Authors: Murphy, Nick; Treacy, Oliver; Lynch, Kevin; Morcos, Maurice; Lohan, Paul; Howard, Linda; Fahy, Gerry; Griffin, Matthew D.; Ryan, Aideen E.; Ritter, Thomas Journal: FASEB journal Issue: Volume 33:Issue 8(2019) Page Start: 9404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗